Arkolith/Insider Trading/DNA/Form 4

Shetty Reshma P.

See remarks, Director, 10% OwnerGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Apr 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$802K
Net Open-Market Flow
-$802K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 10, 2026Sell(S)125K$6.43$802K436K
Apr 9, 2026Option exercise(M)252K——561K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 9, 2026Option exercise(M)252K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-024927) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML